Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

- Add to watchlist
- Create an alert
- This stock can be held in a




972.00p
976.84p
1,278.00p
1,064.02
975.00p
962.21p
725.00p
-9.21%
9.00p (0.93%) Previous:
9.00p
27,264
n/a
GBX
Price
-
Net Asset Value (NAV)

Performance
1 week 1W | 0.61% | 1 year 1Y | 16.52% |
---|---|---|---|
1 month 1M | 11.05% | 2 years 2Y | 20.21% |
3 months 3M | 18.9% | 3 years 3Y | 24.05% |
6 months 6M | 3.61% | 5 years 5Y | 23.81% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | No |
Ongoing charge: | 1.10% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £482m |
Gross gearing: | 111% |
Market capitalisation:Market cap.: | £393m |
Shares in issue: | 40.71 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 1,064.02 |
---|---|
Latest actual NAV: | 921.36 |
Latest actual NAV date: | 22 February 2022 |
Premium/Discount: | -9.21% |
12m average Premium/Discount: | -3.96% |
NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
Biomarin Pharmaceutical Inc | 5.54% |
Seagen Inc Ordinary Shares | 4.89% |
Horizon Therapeutics plc Ordinary Shares | 4.78% |
Keros Therapeutics Inc | 4.73% |
Syndax Pharmaceuticals Inc | 4.21% |
GH Research PLC | 4.11% |
Yisheng B - Pfd | 4.09% |
Xenon Pharmaceuticals Inc | 3.87% |
Gilead Sciences Inc | 3.70% |
Vaxcyte Inc Ordinary Shares | 3.52% |
Sector | Weight |
---|---|
Healthcare | 100.32% |
Country | Weight |
---|---|
United States | 79.56% |
Canada | 7.29% |
China | 5.46% |
Ireland | 4.11% |
United Kingdom | 2.48% |
France | 0.53% |
Germany | 0.34% |
Switzerland | 0.29% |
Singapore | 0.23% |
Denmark | 0.10% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2023 |

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.